SCHEMBL2787580

SCHEMBL2787580

[CH2]COc1ccc(C(C)(C)c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ KMT2A Q03164 7/20 0.57
▸ MEN1 O00255 6/20 0.57
▸ KDM4E B2RXH2 9/20 0.53
▸ POLB P06746 2/20 0.53
▸ ALDH1A1 P00352 8/20 0.51
▸ HTT P42858 1/20 0.51
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ ESR1 P03372 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ ESR2 Q92731 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ TP53 P04637 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17491754 0.92 ALDH1A1 (0.52) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL14280093 0.84 SMN1; SMN2 (0.66) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL28351762 0.84 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL9787289 0.82 SMN1; SMN2 (0.74) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL12128744 0.82 SMN1; SMN2 (0.64) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL28908712 0.81 SMN1; SMN2 (0.62) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL11121843 0.80 SMN1; SMN2 (0.57) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL8672714 0.80 SMN1; SMN2 (0.71) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL3141888 0.79 SMN1; SMN2 (0.55) SMN1; SMN2KMT2AMEN1KDM4EPOLB
SCHEMBL8673557 0.79 SMN1; SMN2 (0.70) SMN1; SMN2KMT2AMEN1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11998621-B2 Transparent, fracture-tough polymerization resins for the production of dental shaped bodies IVOCLAR VIVADENT AG (LI) 2024-06-04 — — US claimed
WO-2023121292-A1 POLYMER COMPOUND AND APPLICATION THEREOF 주식회사 삼양사 2023-06-29 — — WO claimed
CN-115300400-A Transparent, fracture-tough polymeric resins for the production of dental molded bodies 义获嘉伟瓦登特公司 2022-11-08 — — CN claimed
CN-115160353-A Compound for packaging OLED device, ink composition, packaging film and organic electroluminescent device 吉林奥来德光电材料股份有限公司 2022-10-11 — — CN claimed
US-10700133-B2 Organic light emitting display SAMSUNG SDI CO., LTD. (KR) 2020-06-30 — — US claimed
US-20180158880-A1 ORGANIC LIGHT EMITTING DISPLAY SAMSUNG SDI CO., LTD. (KR) 2018-06-07 — — US claimed
WO-2013075293-A1 PROCESS FOR EMULSION POLYMERIZING HYDROPHOBIC MONOMERS EVONIK INDUSTRIES AG (DE) 2013-05-30 — — WO claimed
US-20080227885-A1 Active Energy Beam-Curable Composition for Optical Material TOAGOSEI CO., LTD. (JP) 2008-09-18 — — US claimed
EP-4383312-A1 FILM FOR TEMPORARY FIXATION, LAYERED PRODUCT FOR TEMPORARY FIXATION, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE Resonac Corporation (JP) 2024-06-12 — — EP disclosed
US-11998621-B2 Transparent, fracture-tough polymerization resins for the production of dental shaped bodies IVOCLAR VIVADENT AG (LI) 2024-06-04 — — US disclosed
CN-118053799-A Method for manufacturing semiconductor device 株式会社力森诺科 2024-05-17 — — CN disclosed
US-20240093059-A1 SEMICONDUCTOR DEVICE MANUFACTURING METHOD, CURABLE RESIN COMPOSITION FOR TEMPORARY FIXATION MATERIAL, FILM FOR TEMPORARY FIXATION MATERIAL, AND LAMINATED FILM FOR TEMPORARY FIXATION MATERIAL RESONAC CORPORATION (JP) 2024-03-21 — — US disclosed
WO-2024034464-A1 ADHESIVE FILM FOR CIRCUIT CONNECTION, CIRCUIT CONNECTION STRUCTURE, AND MANUFACTURING METHOD THEREFOR 株式会社レゾナック 2024-02-15 — — WO disclosed
CN-117238828-A Laminate for temporary fixation and method for manufacturing semiconductor device 株式会社力森诺科 2023-12-15 — — CN disclosed
US-20080194727-A1 Active Energy Beam-Curable Composition TOAGOSEI CO., LTD. (JP) 2008-08-14 — — US disclosed
US-7342053-B2 Resin composition, adhesive film using the same and multilayer printed circuit board AJINOMOTO CO., INC. (JP) 2008-03-11 — — US disclosed
EP-1857469-A1 ACTIVE ENERGY RAY-CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2007-11-21 — — EP disclosed
EP-1857477-A1 (METH)ACRYLATE COMPOUND, PROCESS FOR PRODUCTION OF THE COMPOUND, (METH)ACRYLATE COPOLYMER, PROCESS FOR PRODUCTION OF THE COPOLYMER, AND SOFT INTRAOCULAR LENS HOYA CORPORATION (JP) 2007-11-21 — — EP disclosed
EP-1855277-A2 Optical recording medium-producing sheet and optical recording medium and methods of producing the same Lintec Corporation (JP) 2007-11-14 — — EP disclosed
US-20050187311-A1 Resin composition, adhesive film using the same and multilayer printed circuit board AJINOMOTO CO., INC (JP) 2005-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11998621-B2 Transparent, fracture-tough polymerization resins for the production of dental shaped bodies MMAB, VCL, BOLA2; BOLA2B SMN1; SMN2 3002/4885KMT2A 2161/4885MEN1 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback